You are not authorized to access this page.
Search Within

Yanming Zhang

Formats
  1. Journal Article (96)
  2. Meeting Abstract (92)
  3. Research Letter (11)
  4. Review (3)
  5. Editorial (1)
Groups
  1. Department of Pathology and Laboratory Medicine (203)
  2. Department of Medicine (125)
  3. Center for Hematologic Malignancies (113)
  4. Hematologic Malignancies, Division of (109)
  5. Sloan Kettering Institute Postdocs (73)
  6. GSK Faculty (71)

More Groups

People
  1. Ahmet Dogan (59)
  2. Mikhail Roshal (58)
  3. Maria Arcila (55)
  4. Wenbin Xiao (49)
  5. Martin Tallman (34)
  6. Ross Levine (30)

More People

Years
  1. 2025 (7)
  2. 2024 (27)
  3. 2023 (29)
  4. 2022 (26)
  5. 2021 (25)
  6. 2020 (36)

More Years

Publications
  1. Blood (45)
  2. Modern Pathology (23)
  3. Laboratory Investigation (20)
  4. Blood Advances (11)
  5. Genes Chromosomes and Cancer (7)
  6. Nature Communications (6)

More Publications

Publishers
  1. American Society of Hematology (56)
  2. Nature Publishing Group (35)
  3. Nature Research (24)
  4. Elsevier Inc. (13)
  5. Wiley Blackwell (9)
  6. American Association for Cancer Research (7)

More Publishers

Results (203)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Primary renal sarcoma with SS18::POU5F1 gene fusion
    Journal Article

    Argani, P.; Matoso, A.; Gross, J. M.; Zhang, Y.; SoRelle, J. A.; Gagan, J.; Antonescu, C. R.; Palsgrove, D.
    Genes Chromosomes and Cancer (2022)

    Fulltext@MSK | Save
  • Acute myeloid leukemia with an MN1-ETV6 fusion in a young child with Down syndrome
    Journal Article

    Rosenzweig, J.; Pillai, P. M.; Prockop, S.; Benayed, R.; Eidenschink Brodersen, L.; Najfeld, V.; Loken, M. R.; Zhang, Y.; Shukla, N.
    Cold Spring Harbor Molecular Case Studies (2022)

    Fulltext@MSK | Save
  • Immunophenotypic and molecular profiling of chronic myeloid leukemia (CML) in T-cell lineage blast phase
    Meeting Abstract

    Abdelmalak, R.; Gao, Q.; Petrova-Drus, K.; Zhang, Y.; Xiao, W.; Roshal, M.; Galera, P.
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Tumor stroma originates from bone marrow-derived mesenchymal cells: An in situ analysis of cancer samples from patients post allogeneic sex-mismatched bone marrow transplant
    Meeting Abstract

    Derakhshan, F.; Li, Y.; Birsoy, O.; Dopeso, H.; Pareja, F.; Ptashkin, R.; El Jabbour, T.; Wen, H.; Brogi, E.; Weigelt, B.; more...
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Immunophenotypic and molecular profiling of chronic myeloid leukemia (CML) in T-cell lineage blast phase
    Meeting Abstract

    Abdelmalak, R.; Gao, Q.; Petrova-Drus, K.; Zhang, Y.; Xiao, W.; Roshal, M.; Galera, P.
    Laboratory Investigation (2022)

    Fulltext@MSK | Save
  • Bone marrow surveillance of pediatric cancer survivors identifies clones that predict therapy-related leukemia
    Journal Article

    Spitzer, B.; Rutherford, K. D.; Gundem, G.; McGovern, E. M.; Millard, N. E.; Arango Ossa, J. E.; Cheung, I. Y.; Gao, T.; Levine, M. F.; Zhang, Y.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasm
    Journal Article

    Miltiadous, O.; Petrova-Drus, K.; Kaicker, S.; Mathew, S.; Kluk, M.; Geyer, J. T.; Rodriguez-Sanchez, I.; Bouvier, N.; Inghirami, G.; Stieglitz, E.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Reduced plasmacytoid dendritic cell output is associated with high risk in low-grade myelodysplastic syndrome
    Research Letter

    Chan, A.; Liu, Y.; Devlin, S.; Gao, Q.; Baik, J.; Sigler, A.; Londono, D.; Arcila, M.; Levine, R.; Dogan, A.; more...
    HemaSphere (2022)

    Fulltext@MSK | Save
  • Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML
    Journal Article

    Menghrajani, K.; Gomez-Arteaga, A.; Madero-Marroquin, R.; Zhang, M. J.; Bo-Subait, K.; Sanchez, J.; Wang, H. L.; Aljurf, M.; Assal, A.; Bacher, V. U.; more...
    Blood Advances (2022)

    Fulltext@MSK | Save
  • Genomic and immune signatures predict sustained MRD negativity in newly diagnosed multiple myeloma patients treated with daratumumab, carfilzomib, lenalidomide, and dexamethasone (D-KRd)
    Meeting Abstract

    Maura, F.; Boyle, E. M.; Diamond, B.; Blaney, P.; Ghamlouch, H.; Ziccheddu, B.; Wang, Y.; Maclachlan, K. H.; Hoffman, J. E.; Hassoun, H.; more...
    Blood (2021)

    Fulltext@MSK | Save